Search results for "Drug Storage"

showing 10 items of 18 documents

Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months

2016

Up to 80% of the cost of vaccination programmes is due to the cold chain problem (that is, keeping vaccines cold). Inexpensive, biocompatible additives to slow down the degradation of virus particles would address the problem. Here we propose and characterize additives that, already at very low concentrations, improve the storage time of adenovirus type 5. Anionic gold nanoparticles (10−8–10−6 M) or polyethylene glycol (PEG, molecular weight ∼8,000 Da, 10−7–10−4 M) increase the half-life of a green fluorescent protein expressing adenovirus from ∼48 h to 21 days at 37 °C (from 7 to >30 days at room temperature). They replicate the known stabilizing effect of sucrose, but at several orders of…

0301 basic medicineSucroseSucroseTime FactorsvirusesGeneral Physics and AstronomyMetal Nanoparticles02 engineering and technologyvaccinationsvaccine storagePolyethylene Glycolschemistry.chemical_compoundMiceImmunogenicity VaccineDrug StabilityModelsAdenovirus Vaccinesvaccineta318ta317MultidisciplinaryChemistryImmunogenicityadenoviruksetQadenovirus021001 nanoscience & nanotechnologyImmunogenicityOrders of magnitude (mass)Cold Temperaturevaccine; adenovirus; additives; nanoparticlesInfectious DiseasesColloidal goldModels Animaladditives0210 nano-technologyInfectionBiotechnologyHalf-LifeScienceDrug StorageBioengineeringPolyethylene glycolModels BiologicalGeneral Biochemistry Genetics and Molecular BiologyArticleVaccine RelatedExcipients03 medical and health sciencesPEG ratioAnimalsThermal stabilityChromatographyAnimalPreventionRational designta1182General ChemistryBiologicalVirology030104 developmental biologyadenovirusesFeasibility StudiesImmunizationnanoparticlesGoldVaccine
researchProduct

New binary solid dispersion of indomethacin with surfactant polymer: From physical characterization to in vitro dissolution enhancement

2009

This article investigated preparation of solid dispersions containing a poor water-soluble drug, indomethacin (IND), and a new surfactant polymer, polyoxyethylene 32 distearate (POED). Solid dispersions were prepared by the melting method and characterized by DSC, hot-stage microscopy (HSM), X-ray diffraction (XRD) and scanning electron microscopy (SEM). DSC and HSM analyses performed on IND/POED physical mixtures indicated that IND could dissolve in liquid POED. The materials showed complete miscibility at liquid state. Combination of DSC, XRD, and SEM revealed that these materials had limited miscibility at the solid state. Up to 20% w/w IND in POED, we did not detect significant modifica…

Drug CarriersRecrystallization (geology)PolymersChemistryDrug CompoundingDrug StorageIndomethacinPharmaceutical ScienceMiscibilityPolyethylene GlycolsSurface-Active AgentsDifferential scanning calorimetryDrug StabilitySolubilityPulmonary surfactantChemical engineeringOrganic chemistryCrystalliteSolubilityCrystallizationDissolutionSolid solutionJournal of Pharmaceutical Sciences
researchProduct

Loading, release and stability of epirubicin-loaded drug-eluting beads.

2015

Purpose The aim of this study was to determine the loading efficiency, physico-chemical stability and release of epirubicin-loaded DC Bead™ (Biocompatibles UK Ltd, a BTG International group company) (bead size 70–150 µm (=DC Bead M1™) and 100–300 µm) after loading with epirubicin solution (2 mg/ml) or reconstituted powder formulation (25 mg/ml) and controlled storage. Methods DC Bead™ were loaded with 76 mg epirubicin solution (Epimedac™, Medac GmbH) or 75 mg epirubicin powder formulation (Farmorubicin™, Pharmacia Pfizer GmbH) per 2 ml of beads. Drug loading efficiency and stability were determined by measuring the epirubicin concentration in the excess solution after predetermined interval…

Drug CompoundingDrug StorageBead030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineDrug StabilitymedicinePharmacology (medical)Particle SizeChromatography High Pressure LiquidEpirubicinDrug CarriersChromatographyAntibiotics AntineoplasticDrug eluting beadsElutionbusiness.industrySyringesMicrospheresOncology030220 oncology & carcinogenesisvisual_artDrug releasevisual_art.visual_art_mediumPowdersbusinessEpirubicinmedicine.drugJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
researchProduct

Stability of tacrolimus ophthalmic solution

2017

Purpose The stability of 0.3-mg/mL tacrolimus ophthalmic solution at different storage temperatures was studied. Methods A sterile ophthalmic solution of 0.3 mg/mL tacrolimus was prepared in triplicate under aseptic conditions by diluting tacrolimus in eye drops. Three aliquots of this solution were transferred into polypropylene bottles and stored at 25, 2–8, or −15 to −25 °C. Samples were collected immediately after preparation and at selected time points and assayed in triplicate using high-performance liquid chromatography (HPLC). Samples were also visually examined for macroscopic changes. The 0.3-mg/mL tacrolimus solution was also exposed to acidic treatment and heat to force its degr…

Drug Storagemedicine.medical_treatmentAdministration Ophthalmicchemical and pharmacologic phenomena030226 pharmacology & pharmacyHigh-performance liquid chromatographyTacrolimus03 medical and health sciences0302 clinical medicineDrug StabilitymedicineHumansChromatography High Pressure LiquidPharmacologyChromatographyChemistryHealth PolicyTemperatureEye dropTacrolimusPharmaceutical Solutionssurgical procedures operativeOphthalmic solutionsAnesthesia030221 ophthalmology & optometryAseptic processingOphthalmic SolutionsImmunosuppressive AgentsAmerican Journal of Health-System Pharmacy
researchProduct

Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids

2011

A novel drug delivery system for beclomethasone dipropionate (BDP) has been constructed through self-assembly of a pegylated phospholipid-polyaminoacid conjugate. This copolymer was obtained by chemical reaction of α,β-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA) with 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethyleneglycol)2000] (DSPE-PEG(2000)-NH(2)). Benefiting from the amphiphilic structure with the hydrophilic shell based on both PHEA and PEG and many hydrophobic stearoyl tails, PHEA-PEG(2000)-DSPE copolymer was able to self assemble into micelles in aqueous media above a concentration of 1.23 × 10(-7)M, determined by fluorescence studies. During the self-assembling …

ErythrocytesBiocompatibilityCell SurvivalDrug CompoundingDrug StorageALPHABETA-Poly(N-2-hydroxyethyl)-dl- aspartamide (PHEA) 12-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethyleneglycol)2000](DSPE-PEG2000-NH2) Polymeric micelles Drug delivery Beclomethasone dipropionate (BDP) Pulmonary diseasesPhospholipidPharmaceutical Science[object Object]HemolysisMicelleCell LinePolyethylene Glycolschemistry.chemical_compoundDrug StabilityAmphiphilePEG ratioPulmonary diseasesHumans?Beclomethasone dipropionate (BDP)Particle SizeLungMicellesDrug CarriersChromatographyAqueous solutionMolecular StructureChemistryPhosphatidylethanolaminesBeclomethasonetechnology industry and agriculture?-Poly(N-2-hydroxyethyl)-dl-aspartamide (PHEA)Spectrometry FluorescenceSolubilitySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliveryDrug deliveryPolymeric micellesNanocarriersPeptidesHydrophobic and Hydrophilic InteractionsNuclear chemistry
researchProduct

Implementation and microbiological stability of dose-banded ganciclovir infusion bags prepared in series by a robotic system.

2018

Objectives The implementation of dose-banding (DB) in centralised, pharmacy-based cytotoxic drug preparation units allows the preparation of standardised doses in series. The aim of this study was to evaluate the feasibility of DB for the prescribing of ganciclovir (GV) infusion solutions and to investigate the microbiological stability of dose-banded, automatically prepared ready-to-administer GV infusion bags by media-fill simulation tests and sterility tests. Methods The frequency of prescription of GV doses was retrospectively analysed before and after implementing the DB scheme. Four dose-ranges or ‘bands’ and the corresponding standard doses (250, 300, 350, 400 mg) were identified. Th…

GanciclovirCytotoxic drugSterilityDrug CompoundingDrug StorageGrowth promotion030226 pharmacology & pharmacyAntiviral AgentsStandard PreparationsExtended storage03 medical and health sciences0302 clinical medicineAnimal scienceDrug StabilityRefrigerationMedicineInfusions Parenteral030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsGanciclovirDrug PackagingRetrospective StudiesOriginal Researchbusiness.industryReproducibility of ResultsRoboticsRobotic systemsAseptic processingbusinessDrug ContaminationPharmacy Service Hospitalmedicine.drugEuropean journal of hospital pharmacy : science and practice
researchProduct

Fostering drug.storage,preparation and treatment modalities improves adherence to treatment with turoctocog-alfa in patients with haemophilia A:resul…

2019

Haemophilia Adrug storagetreatment adherence
researchProduct

The Effect of Fluctuating Temperature on the Stability of Turoctocog Alfa for Hemophilia A

2019

Abstract Background and objective Factor VIII (FVIII) is indicated for the prevention or treatment of bleeding in patients with hemophilia A. FVIII product stability under high and fluctuating temperatures is important, particularly for patients who reside in, or travel to, regions with high ambient temperatures, as they may remove their product from the refrigerator and return it, unused, multiple times. We evaluated the effect of variable temperature storage conditions, including up to 40 °C, on the stability of the recombinant FVIII product, turoctocog alfa. Methods Turoctocog alfa dry powder stability was assessed when moved between storage conditions of 5 °C (ambient humidity) and 40 °…

Hot TemperatureTime FactorsDrug StoragePharmacology toxicologyHemophilia A030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineAnimal scienceDrug StabilityAmbient humidityHumansPotencyRelative humidityIn patientOriginal Research Article030203 arthritis & rheumatologyPharmacologyFactor VIIIChemistrylcsh:RM1-950Turoctocog alfaCoagulation Factor VIII Room TemperatureStability Turoctocog-alfaRecombinant ProteinsCold TemperatureMolecular Weightlcsh:Therapeutics. PharmacologyDry powderOxidation-ReductionDrugs in R&D
researchProduct

The influence of local anesthetic solutions storage on tissue inflammatory reaction

2009

Objective: This study aimed to analyze the influence of storage conditions of local anesthetic solutions in the inflammatory reaction after injection in rats. Study design: Twenty-four rats received in their oral mucosa the injection of 2% lidocaine with epinephrine 1:100.000 solutions (LA) submitted to the following storage conditions during a twelve-month period: G1 - inside the original packaging, in refrigerator (5±1°C); G2 - inside the original box, under light shelter, at room temperature; G3 - outside the original box at room temperature (exposed to artificial light for 12 hours/day) and G4 - brand new solution. For the controls tests, 0.9% sodium chloride solution was injected in th…

MaleStomatitisArtificial lightLidocaineChemistryLocal anestheticmedicine.drug_classSodiumDrug Storagechemistry.chemical_element:CIENCIAS MÉDICAS [UNESCO]RatsEpinephrinemedicine.anatomical_structureOtorhinolaryngologyAnesthesiaUNESCO::CIENCIAS MÉDICASmedicineAnimalsSurgeryOral mucosaAnesthetics LocalRats WistarGeneral Dentistrymedicine.drug
researchProduct

Spray freeze drying as an alternative technique for lyophilization of polymeric and lipid-based nanoparticles.

2016

The use of nanoparticles for drug delivery is still restricted by their limited stability when stored in an aqueous medium. Freeze drying is the standard method for long-term storage of colloidal nanoparticles; however the method needs to be elaborated for each formulation. Spray freeze drying (SFD) is proposed here as a promising alternative for lyophilizing colloidal nanoparticles. Different types of polymeric and lipid nanoparticles were prepared and characterized. Afterwards, samples were spray freeze dried by spraying into a column of cold air with a constant concentration of different cryoprotectants, and the frozen spherules were collected for further freeze drying. Similar samples w…

Materials scienceCryoprotectantPolymersChemistry PharmaceuticalDrug StoragePharmaceutical ScienceNanoparticle02 engineering and technology030226 pharmacology & pharmacy03 medical and health sciencesFreeze-drying0302 clinical medicineDrug Delivery SystemsDrug StabilityLipid based nanoparticlesColloidsPorosityNanocompositeChromatographyCold air021001 nanoscience & nanotechnologyLipidsFreeze DryingSolubilityDrug deliveryNanoparticles0210 nano-technologyPorosityInternational journal of pharmaceutics
researchProduct